Eberle, R.J.; Gering, I.; Tusche, M.; Ostermann, P.N.; Müller, L.; Adams, O.; Schaal, H.; Olivier, D.S.; Amaral, M.S.; Arni, R.K.;
et al. Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold. Pharmaceuticals 2022, 15, 540.
https://doi.org/10.3390/ph15050540
AMA Style
Eberle RJ, Gering I, Tusche M, Ostermann PN, Müller L, Adams O, Schaal H, Olivier DS, Amaral MS, Arni RK,
et al. Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold. Pharmaceuticals. 2022; 15(5):540.
https://doi.org/10.3390/ph15050540
Chicago/Turabian Style
Eberle, Raphael J., Ian Gering, Markus Tusche, Philipp N. Ostermann, Lisa Müller, Ortwin Adams, Heiner Schaal, Danilo S. Olivier, Marcos S. Amaral, Raghuvir K. Arni,
and et al. 2022. "Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold" Pharmaceuticals 15, no. 5: 540.
https://doi.org/10.3390/ph15050540
APA Style
Eberle, R. J., Gering, I., Tusche, M., Ostermann, P. N., Müller, L., Adams, O., Schaal, H., Olivier, D. S., Amaral, M. S., Arni, R. K., Willbold, D., & Coronado, M. A.
(2022). Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold. Pharmaceuticals, 15(5), 540.
https://doi.org/10.3390/ph15050540